Clinical trials
Active, not recruiting Epilepsy trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Longboard Pharmaceuticals | 2 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Biohaven Therapeutics Ltd. | 1 |
| Eisai Inc. | 1 |
| Eli Lilly and Company | 1 |
| Hospices Civils de Lyon | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Epilepsy | 7 |
| Seizures | 4 |
| Epilepsies, Myoclonic | 2 |
| Neurodevelopmental Disorders | 2 |
| Drug Resistant Epilepsy | 1 |
| Epilepsies, Partial | 1 |
| Lennox Gastaut Syndrome | 1 |
| Neuroblastoma | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.